Daniel E. Bassi

961 total citations
19 papers, 804 citations indexed

About

Daniel E. Bassi is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Daniel E. Bassi has authored 19 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cell Biology and 6 papers in Cancer Research. Recurrent topics in Daniel E. Bassi's work include Ubiquitin and proteasome pathways (9 papers), Cellular transport and secretion (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Daniel E. Bassi is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Cellular transport and secretion (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Daniel E. Bassi collaborates with scholars based in United States, Argentina and Canada. Daniel E. Bassi's co-authors include Andres J. Klein–Szanto, Ricardo López de Cicco, Jian Fu, Haleh Mahloogi, Samuel Litwin, Jirong Zhang, John A. Ridge, James C. Watson, Émmanuelle Nicolas and Stanley Zucker and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Biochemical Pharmacology.

In The Last Decade

Daniel E. Bassi

19 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Bassi United States 14 441 235 234 233 72 19 804
Inés Badano Argentina 10 535 1.2× 273 1.2× 193 0.8× 267 1.1× 58 0.8× 17 892
Ricardo López de Cicco United States 15 567 1.3× 363 1.5× 324 1.4× 251 1.1× 61 0.8× 20 1.0k
Francine Grondin Canada 12 433 1.0× 144 0.6× 184 0.8× 124 0.5× 59 0.8× 16 851
Pavlova Tv Russia 19 657 1.5× 216 0.9× 287 1.2× 152 0.7× 130 1.8× 47 947
Rick Lesniewski United States 8 395 0.9× 261 1.1× 151 0.6× 129 0.6× 48 0.7× 10 649
Jeou-Yuan Chen Taiwan 15 606 1.4× 265 1.1× 139 0.6× 164 0.7× 54 0.8× 26 986
María José Sandí France 13 462 1.0× 183 0.8× 127 0.5× 166 0.7× 74 1.0× 21 738
Naciba Benlimame Canada 15 465 1.1× 284 1.2× 114 0.5× 247 1.1× 54 0.8× 27 885
Margret B. Einarson United States 16 524 1.2× 163 0.7× 118 0.5× 161 0.7× 78 1.1× 28 760
Monideepa Roy United States 11 779 1.8× 251 1.1× 113 0.5× 206 0.9× 53 0.7× 18 1.1k

Countries citing papers authored by Daniel E. Bassi

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Bassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Bassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Bassi more than expected).

Fields of papers citing papers by Daniel E. Bassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Bassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Bassi. The network helps show where Daniel E. Bassi may publish in the future.

Co-authorship network of co-authors of Daniel E. Bassi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Bassi. A scholar is included among the top collaborators of Daniel E. Bassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Bassi. Daniel E. Bassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Klein–Szanto, Andres J. & Daniel E. Bassi. (2019). Keep recycling going: New approaches to reduce LDL-C. Biochemical Pharmacology. 164. 336–341. 38 indexed citations
2.
Klein–Szanto, Andres J. & Daniel E. Bassi. (2017). Proprotein convertase inhibition: Paralyzing the cell’s master switches. Biochemical Pharmacology. 140. 8–15. 36 indexed citations
3.
Bassi, Daniel E., et al.. (2016). Targeting proprotein convertases in furin‐rich lung cancer cells results in decreased in vitro and in vivo growth. Molecular Carcinogenesis. 56(3). 1182–1188. 29 indexed citations
4.
Bassi, Daniel E., Jonathan Cenna, Jirong Zhang, Edna Cukierman, & Andres J. Klein–Szanto. (2014). Enhanced aggressiveness of benzopyrene‐induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Molecular Carcinogenesis. 54(10). 1122–1131. 7 indexed citations
5.
Fu, Jian, Daniel E. Bassi, Jirong Zhang, et al.. (2013). Enhanced UV-Induced Skin Carcinogenesis in Transgenic Mice Overexpressing Proprotein Convertases. Neoplasia. 15(2). 169–179. 14 indexed citations
6.
Fu, Jian, Daniel E. Bassi, Jirong Zhang, et al.. (2012). Transgenic Overexpression of the Proprotein Convertase Furin Enhances Skin Tumor Growth. Neoplasia. 14(4). 271–282. 23 indexed citations
7.
Bassi, Daniel E., Jian Fu, Jirong Zhang, & Andres J. Klein–Szanto. (2012). The Role of Proprotein Convertases in Animal Models of Skin Carcinogenesis. 1(1). 1–60. 1 indexed citations
8.
Bassi, Daniel E., Jirong Zhang, Jonathan Cenna, et al.. (2010). Proprotein Convertase Inhibition Results in Decreased Ski Proliferation, Tumorigenesis, and Metastasis. Neoplasia. 12(7). 516–IN1. 36 indexed citations
9.
Page, Robert E., Andres J. Klein–Szanto, Samuel Litwin, et al.. (2007). Increased Expression of the Pro‐Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer. Analytical Cellular Pathology. 29(4). 289–299. 71 indexed citations
10.
Cicco, Ricardo López de, et al.. (2007). Inhibition of proprotein convertases: Approaches to block squamous carcinoma development and progression. Molecular Carcinogenesis. 46(8). 654–659. 23 indexed citations
11.
Bassi, Daniel E., Jian Fu, Ricardo López de Cicco, & Andres J. Klein–Szanto. (2005). Proprotein convertases: “Master switches” in the regulation of tumor growth and progression. Molecular Carcinogenesis. 44(3). 151–161. 193 indexed citations
12.
Cicco, Ricardo López de, Daniel E. Bassi, Stanley Zucker, Nabil G. Seidah, & Andres J. Klein–Szanto. (2005). Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin. Cancer Research. 65(10). 4162–4171. 44 indexed citations
13.
Khatib, Abdel‐Majid, Daniel E. Bassi, Géraldine Siegfried, Andres J. Klein–Szanto, & L’Houcine Ouafik. (2005). Endo/exo-proteolysis in neoplastic progression and metastasis. Journal of Molecular Medicine. 83(11). 856–864. 13 indexed citations
14.
Cicco, Ricardo López de, et al.. (2004). Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression. Clinical Cancer Research. 10(13). 4480–4488. 69 indexed citations
15.
Bassi, Daniel E., et al.. (2001). Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Molecular Carcinogenesis. 31(4). 224–232. 114 indexed citations
16.
Bassi, Daniel E., et al.. (2000). The Proprotein Convertases Furin and PACE4 Play a Significant Role in Tumor Progression. Molecular Carcinogenesis. 28(2). 63–69. 67 indexed citations
17.
Faletti, A., Daniel E. Bassi, A.L. Gimeno, & M.A.F. Gimeno. (1992). Effects of β-endorphin on spontaneous uterine contractions. Prostaglandins production and 45Ca2+ uptake in uterine strips from ovariectomized rats. Prostaglandins Leukotrienes and Essential Fatty Acids. 47(1). 29–33. 10 indexed citations
18.
Faletti, A., Daniel E. Bassi, A.M. Franchi, A.L. Gimeno, & M.A.F. Gimeno. (1990). Effects of morphine on arachidonic acid metabolism, on Ca2+- uptake and on cAMP synthesis in uterine strips from spayed rats. Prostaglandins Leukotrienes and Essential Fatty Acids. 41(3). 151–155. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026